Estrogen receptor beta

From WikiMD's WELLNESSPEDIA

The Estrogen Receptor Beta (ERβ) is a protein that plays a crucial role in mediating the effects of estrogen in various tissues and organs of the human body. It is a member of the nuclear receptor superfamily and is encoded by the ESR2 gene.

Structure[edit]

ERβ is composed of several functional domains, including a DNA-binding domain, a ligand-binding domain, and two transcription activation domains. The DNA-binding domain allows ERβ to bind to specific DNA sequences known as estrogen response elements (EREs), while the ligand-binding domain enables the receptor to interact with estrogen and other ligands.

Function[edit]

ERβ functions as a transcription factor, meaning it regulates the expression of target genes by binding to specific DNA sequences and recruiting other proteins involved in gene transcription. When estrogen binds to ERβ, it triggers a series of molecular events that ultimately lead to changes in gene expression.

ERβ is expressed in various tissues, including the brain, reproductive organs, bone, and cardiovascular system. Its role in these tissues is diverse and complex. In the brain, ERβ is involved in neuroprotection, cognition, and mood regulation. In the reproductive organs, it regulates the growth and development of the uterus, ovaries, and mammary glands. In bone, ERβ plays a role in maintaining bone density and preventing osteoporosis. In the cardiovascular system, it influences vascular function and protects against cardiovascular diseases.

Clinical Significance[edit]

ERβ has been implicated in various diseases and conditions. For example, alterations in ERβ expression or function have been associated with breast cancer, prostate cancer, endometriosis, and neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Understanding the role of ERβ in these conditions may provide insights into potential therapeutic strategies.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.